News

Recent News
Our scientific leader Prof. Dr. Adil Mardinoğlu has received the 100th Year Anniversary TÜBİTAK Special Science Award in recognition of his work and achievements in the fields of cell biology and molecular biology.
Scientific Documents
Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose induced metabolic dysfunction in rats
Scientific Documents
Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme
Scientific Documents
Synthesis And Biological Assessment of BUB1B Inhibitors for The Treatment of Clear Cell Renal Cell Carcinoma
Scientific Documents
Synthesis of novel tetrahydrobenzo[b]thiophene-3-carbonitrile (THBTC)-based heterocycles: Structural insights, reactivity profiles, and in-silico bioactivity studies
Patents
Prostat Adenokarsinomu Tedavisi İçin Kullanima Uygun Yeni Etken Bileşikler
Patents
Prostat Adenokarsinom Hastalıklarının Tedavisinde Kullanıma Uygun Yeni Terapötik Hedef Gen ve Söz Konusu Terapötik Hedef Genlere Uygun Bir İlaç Adayı
Patents
Treatment of Lung Adenocarcinoma - PCT
Patents
Parbendazole For Use In The Treatment Of Dementia - PCT
Patents
Treatment of Lung Adenocarcinoma - EPO
Patents
Treatment of Dementia Using Bortezomib or Parbendazole - EPO
Recent News
Trustlife Ventures continues on its path with the investment of Alkima Partners (‘Alkima’).
Patents
New Therapeutic Target Gene Suitable for Use in TheTreatment of Prostate Adenocarcinoma Diseases and New Active Compounds Suitable for The Therapeutic Target Gene and Gene Products
Visits
Trustlife Scientific Leadership Visits Minister of Health
Patents
Small Molecule Treatment of Fatty Liver Disease and HCC -PCT
Patents
Small Molecule Treatment of Fatty Liver Disease and HCC - EPO
Scientific Documents
Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins
Scientific Documents
Design and evaluation of novel inhibitors for the treatment of clear cell renal cell carcinoma
Scientific Documents
Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma.
Scientific Documents
Synthesis, spectroscopic characterization, DFT and molecular docking of N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl) naphthalene-1-sulfonamide derivatives
Scientific Documents
Unveiling Structural Features, Chemical Reactivity, and Bioactivity of a Newly Synthesized Purine Derivative through Crystallography and Computational Approaches
Recent News
Bülent Denkdemir, CEO of Trustlife Ventures: At Trustlife, we conduct drug development studies using very advanced algorithms based on human data and artificial intelligence.
Recent News
Recent News
Trustlife Labs Pharmaceutical R&D Centre: Drug Discovery and Development Process
Recent News
Another Award to Prof. Dr. Adil Mardinoğlu
Scientific Documents
Trustlife Labs Pharmaceutical R&D Centre - Interviews
Visits
Main Consul of the United Kingdom in Istanbul and Undersecretary of Commerce for the Eastern Europe and Central Asia Network, Mr. Kenan Poleo visited Truslife.
Recent News
Trustlife 2023 Investment Fund Activity Report
Recent News
Turkey's National Health Technologies Platform
Visits
Bioexpo 2023 Panel: The Role of Artificial Intelligence in Drug Development
Scientific Documents
Discovery of Small Molecules As Potential Therapeutics For NAFLD and HCCBAU Conference Presentation
Recent News
Trustlife Corporate Infographic Presentation
Scientific Documents
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridging the Gap from Lab to Clinic
Scientific Documents
Small Molecular inhibitors of Aurora kinase B; From Structural Insight to Mechanism Based Design
Recent News
Systems Biology & Artificial Intelligence Based Drug Development
Scientific Documents
Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis
Scientific Documents
Tailoring Liver Pyruvate Kinase Inhibitors via Structural Guided Optimization
Recent News
Trustlife Corporate Promotion
Recent News
Trustlife Turkey - Current Platform Structure
Recent News
Bioinformatics is a rewarding career in need of new recruits
Patents
New Compounds and Treatment of Renal Cell Carcinoma
Scientific Documents
Drug Repositioning Targeting Glutaminase Reveals Drug Candidates for The Treatment of Alzheimer’s Disease Patients
Scientific Documents
Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase
Scientific Documents
Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma
Scientific Documents
Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase
Project Calls
Innovative Drug (Small Molecule) Development Project Call Results Announced
Project Calls
Trustlife Panelist Selection Has Been Made
Scientific Documents
Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
Project Calls
Trustlife Project Call Documentation Released
Project Calls
Project Call Theme Announced
Scientific Documents
Prediction of Drug Candidates for Clear Cell Renal Cell Carcinoma Using A Systems Biology-Based Drug Repositioning Approach
Scientific Documents
Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme
Scientific Documents
Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis
Scientific Documents
Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development